FKBP23 in ER binds to BiP specifically

来源 :中国科学B辑 | 被引量 : 0次 | 上传用户:viviane_px349
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
FKBP23 was found in mouse endoplasmic reticulum (ER) in 1998. It consists of an N-terminal peptidyl-prolyl cis-trans isomerase (PPIase) domain and a C-terminal domain with Ca2+ binding sites. The fusion protein of mouse FKBP23 and glutathione S-transferase (GST), GST-FKBP23, and the fusion protein of BiP, a member of heat shock protein 70 (Hsp 70) in ER, and GST, GST-BiP, were subcloned in E. coli, expressed and purified. The fusion proteins were restrictively digested by Factor Xa (FaXa) to obtain the free cloned proteins FKBP23 and BiP. With the assay of adsorption of free FKBP23 or BiP with GST-BiP or GST-FKBP23 attached to the Glutathione-Sepharose 4B, the adsorbed FKBP23 or BiP could be detected by Immunoblot. It means that FKBP23 binds to BiP. Furthermore, BiP in leukocyte ER-extract can be adsorbed with GST-FKBP23 attached to the glutathione-Sepharose 4B. It shows that FKBP23 binds to natural BiP in ER, too. These experiments show that a PPIase binds to a molecular chaperone of the Hsp70 family.
其他文献
白细胞介素(IL)-18是一种缺乏信号肽的非活性前体蛋白,有调节视网膜病理性新生血管的作用.IL-18通过干扰素-γ、凝血酶致敏蛋白等途径,抑制实验性脉络膜新生血管(CNV)的形成.
糖皮质激素、抗血管内皮生长因子药物、抗生素、抗病毒药物是目前临床常用的4类玻璃体腔注射药物.药物经玻璃体腔注射后,受药物种类、注射剂量以及患者年龄、性别、眼轴、玻
视网膜母细胞瘤(RB)的全身化学药物治疗(化疗)对顽固性或复发性RB玻璃体腔种植者治疗效果较差.近年来,通过玻璃体腔化疗(IVitC)治疗进展期RB及RB玻璃体腔种植患者已取得较好
@@
Pt(Ⅱ) and Pd(Ⅱ) complexes with 2',3',4',5,7-pentahydroxy-flavone were synthesized and characterized by elemental analysis, molar conductance, IR, 1HNMR, TG-DT
@@
特发性黄斑毛细血管扩张症(IPT)是一种以黄斑中心凹及中心凹旁毛细血管扩张为特征的视网膜血管异常性疾病.以视网膜毛细血管扩张、视网膜透明度降低、视网膜小静脉扩张、黄色
抗血管内皮生长因子(VEGF)药物治疗反应存在个体差异.根据治疗前后视网膜中央厚度、视网膜内积液、视网膜下积液等形态和最佳矫正视力等功能变化,患眼的应答表现可分为理想应
@@
@@